PubMed Health⌕ Search

Biomedical subjects

J Lakshmanan

Publications and source records attributed to J Lakshmanan.

At least 37 records · Page 2Linked to original sources

Expression of epidermal growth factor in the rat kidney. An immunocytochemical and in situ hybridization study.

The renal localization and the site of synthesis of epidermal growth factor (EGF) were investigated in the rat kidney by immunohistochemistry and in situ hybridization techniques. EGF was localized in the cells of the thick ascending limb of Henle (TAL) and distal convoluted tubule (DCT). At the ultrastructural level, EGF immunoreactivity was distributed on the apical membrane and trans-Golgi complex of the TAL and DCT cells. These segments of the rat nephron also hybridized to prepro-EGF cRNA probes in a specific manner, indicating that TAL and DCT are the sites of EGF synthesis in the rat kidney.

Animals↗

Identification of pro-epidermal growth factor and high molecular weight epidermal growth factors in adult mouse urine.

By use of immunoblot analysis, we demonstrate the presence of a pro-Epidermal growth factor (EGF) with an approximate molecular weight of 165 kDa in adult mouse urine. In addition, urine contains four high molecular weight EGFs with approximate molecular weights of 116, 97, 66 and 56 kDa. The 165 kDa pro-EGF as well as the 66 and 56 kDa EGFs also are detectable in mouse kidney extract. Neither urine nor kidney contain the mature EGF of 6 kDa. The 165 kDa pro-EGF is the major product synthesized in renal tissue and secreted in urine. The finding of high molecular weight EGFs in urine suggests that part of pro-EGF secreted into urine undergoes partial proteolysis distal to its site of synthesis.

Animals↗

Expression of epidermal growth factor in the kidney and submandibular gland during mouse postnatal development. An immunocytochemical and in situ hybridization study.

Earlier work has demonstrated that the salivary glands and kidneys are the major sites of epidermal growth factor (EGF) synthesis in adult mice. The precise timing of the onset of endogenous EGF synthesis in these tissues is not yet clear. In the present study we assessed the ontogenesis of EGF expression in the Swiss-Webster mouse. Paraformaldehyde-fixed frozen sections of neonatal kidneys and salivary glands were probed with proEGF cRNA labelled with 35S for in situ hybridization and with rabbit antisera to mouse EGF for immunocytochemistry. Both EGF mRNA and immunoreactivity were first detected in the developing distal nephron between days 3 and 5 postpartum. Juxtamedullary nephrons underlying the superficial nephrogenic zone were the first to express EGF. During the 2nd week after birth, EGF-expressing tubules became more abundant and distributed to medullary as well as cortical regions, corresponding to the thick ascending limb of Henle and distal convoluted tubule. Initial EGF mRNA and immunoreactivity in the submandibular gland were first detected between days 18 and 20 postpartum and increased notably during the following weeks.

Animals↗

Transforming growth factor alpha in developing rats.

Transforming growth factor-alpha (TGF-alpha) concentrations were measured in lung, brain, liver, and kidney of rats at three different ages (20 days gestation and 9 and 50 days postnatal). TGF-alpha concentrations were maximal in the lung and brain by 20 days of gestation and showed minimal changes during nursing (day 9) and young adulthood (day 50). The liver, which also showed maximal TGF-alpha concentration by 20 days of gestation, demonstrated a progressive reduction with age to nadir values in the young adult. In contrast to the pattern in other tissues, kidney had the lowest concentration of TGF-alpha in late gestation and showed an increase by 50 days of age. As TGF-alpha acts via the epidermal growth factor (EGF) receptor, its function in development may be analogous to that of EGF. Thus TGF-alpha may have a role in lung maturation and postinjury repair, liver repair and regeneration, and neuronal cell growth.

Aging↗

Metabolism and effects of epidermal growth factor and related growth factors in mammals.

The initial observations of Stanley Cohen in the 1960s established that EGF induced in vivo effects such as precocious eyelid opening and tooth eruption. Subsequently the actions of EGF have been extensively explored in cell culture systems. The receptor for EGF was characterized as a prototype model for other growth factors and the now extensive in vitro data indicate multiple functions for EGF. Moreover, EGF and EGF receptors have been characterized in many tissues, and EGF has been identified in most body fluids of several mammalian species. Interestingly, neither EGF antibody administration to newborn animals nor passive immunization of pregnant rodents against EGF has caused major deleterious effects (except the delay in epidermal maturation events), as might be expected from the in vitro studies. This is in contrast to the effects of nerve growth factor antiserum in developing rodents. Also, to date, no pathological EGF deficiency disorder has been characterized. However, the EGF family of growth factors appears to be important in mammalian development and function, although the precise roles and significance are not yet clear. Members of the family may have a role in embryogenesis and fetal growth since receptors have been identified in fetal tissues. Available evidence suggests that TGF alpha subserves the growth factor family roles in fetal development. In the developing postnatal animal pro-EGF mRNA, immunoreactive EGF, immunoreactive TGF alpha, and EGF receptors are present in many tissues. EGF also is produced and secreted by the maternal mammary gland, and mammary derived EGF appears to be important in gut development in the neonatal rodent. There is now extensive data to indicate important hormone-EGF interactions. In the postnatal period, thyroid and steroid hormones including retinoic acid have been shown to modulate EGF and/or EGF receptors in several tissues. GH increases EGF binding in liver and increases urine EGF concentrations. Moreover, EGF stimulates secretion of several hypothalamic and pituitary hormones, increases placental production of hCG and human chorionic somatomammotropin, increases adrenal cortisol production, and inhibits testicular, ovarian, and thyroid hormone secretions. As summarized in this review EGF has been implicated in a number of developmental events including palate and skin differentiation, growth of hair follicles, eye opening and tooth eruption, lung maturation, gut and liver growth, and differentiation of neurons. These EGF actions probably are mediated via autocrine, paracrine, and endocrine routes. A role for salivary and urine EGF in the maintenance of adult stomal, gut, and urinary epithelial surface integrity seems likely, although not yet proven.(ABSTRACT TRUNCATED AT 400 WORDS)

Amino Acid Sequence↗

Effect of thyroxine administration on the expression of epidermal growth factor in the kidney and submandibular gland of neonatal mice. An immunocytochemical and in situ hybridization study.

The effect of T4 administration on epidermal growth factor (EGF) expression in kidney and submandibular glands (SMG) was studied in newborn mice. EGF messenger RNA (mRNA) abundance and EGF immunoreactivity were assessed by in situ hybridization and immunohistochemical techniques, respectively. T4 treatment on days 0-6 augmented both the in situ hybridization and immunocytochemical signals in kidney but not in SMG on day 7. By contrast, T4 injections on days 7-14 did not alter the in situ hybridization or immunocytochemical signals in kidney but increased both signals in SMG on day 15. Thus, neonatal T4 treatment augments the levels of EGF mRNA as well as EGF immunoreactivity in both kidney and SMG. The T4 effect is manifested during the first week in kidney whereas the SMG responds to T4 treatment only during the second week of life.

Aging↗

Biological actions of 53 kDa nerve growth factor as studied by a blot and culture technique.

A blot and culture technique has been utilized to examine the biological actions of 53,000 Dalton (53 kDa) nerve growth factor (NGF) present in the submaxillary gland (SMG) of adult male and female mice. SMG-proteins were first resolved by sodium dodecylsulfate (SDS) polyacrylamide gel electrophoresis (PAGE) under reducing conditions and then transferred to a nitrocellulose (NTC) sheet by electroblotting. Specific areas corresponding to 53 kDa NGF were cut and cultured with the rat pheochromocytoma cell line, PC-12. NTC strips bearing the 53 kDa NGF band stimulated cell flattening and neurite formation in serum containing growth medium and augmented cell survival in serum-free growth medium. Similar results were obtained with NTC strips bearing the 13 kDa NGF band. The results suggest that 53 kDa NGF, like 13 kDa NGF, exerts both tropic and trophic actions on its target neurons.

Adrenal Gland Neoplasms↗

Biological demonstration of nerve growth factor in the rat pituitary gland.

Explants of anterior, intermediate and posterior pituitary lobes of rats at various ages evoked an intense nerve fibre outgrowth when co-cultured with neonatal sympathetic superior cervical ganglia in a collagen gel medium. Freezing and thawing of pituitary lobes, prior to culture, did not abolish their growth-promoting effect. Since the addition of antiserum to nerve growth factor in the culture medium inhibited totally the stimulative action of both fresh and frozen pituitary explants it is suggested that the stimulation is mediated by nerve growth factor or an immunologically related molecule. Based on the present results it is concluded that nerve growth factor is synthesized by both the anterior, intermediate and posterior lobes throughout the postnatal period, as well as in adult rats. The function of nerve growth factor in the pituitary gland is discussed.

Animals↗

Molecular forms of nerve growth factor in mouse submaxillary glands.

By use of immunoblot analysis, we demonstrate the presence of a nerve growth factor with a relative molecular mass (Mr) of 53,000 in submaxillary glands of adult male and female mice in addition to the 13,000 form previously discovered in this tissue. Both the Mr 53,000 and 13,000 forms of nerve growth factor are present at equal concentrations in salivary glands of male mice while the Mr 53,000 form is present at a greater concentration than the Mr 13,000 form in the glands of female mice. Testosterone pretreatment, however, specifically augments the Mr 13,000 form of nerve growth factor in the salivary glands of female mice. The existence of nerve growth factor with molecular weight of 53,000, which is higher than the molecular size predicted for the two precursor forms of nerve growth factor, suggest the possibility that one of the nerve growth factor precursors or a product derived from it may undergo post-translational modification in submaxillary glands of mice.

Animals↗

Nerve growth factor-like activity in the rat pituitary intermediate lobe.

Nerve growth factor (NGF)-like immunoreactivity was demonstrated in the rat pituitary intermediate lobe by indirect immunofluorescence method using antisera specific to beta-NGF isolated from adult male mouse submaxillary salivary gland. Co-culture of frozen or fresh intermediate lobes with newborn rat superior cervical ganglion resulted in marked fiber growth from the ganglion, which was totally inhibited by NGF antiserum, suggesting the presence in situ and secretion in vitro of biologically active pituitary NGF. Pituitary stalk transection caused decrease in both the NGF immunoreactivity and biological activity. These findings suggest that pituitary NGF level is under neural regulation.

Animals↗

Neonatal hyperthyroidism alters hepatic epidermal growth factor receptor ontogeny in mice.

Epidermal growth factor (EGF) liver receptor ontogeny and somatic growth were studied in mice from day 7 to day 70 postnatally to assess long-term effects of short-term postnatal thyroxine treatment. The mice were given 0.4 micrograms thyroxine/g body weight/day for the 1st wk of life. EGF receptor binding in liver tissue was studied on days 7, 15, 20, 30, and 70 postnatally. Treated animals had accelerated eyelid opening and tooth eruption, and permanent growth retardation was obvious from the second week of life. Hepatic EGF receptor-binding capacity increased markedly in control mice with increasing age in contrast to a very slow increase in treated mice, making the difference statistically significant (P less than 0.01) from day 30. The affinity of EGF receptor binding initially was similar in the two groups of animals (1.09 x 10(9) M-1 and 1.02 x 10(9) M-1) and increased by day 30 in controls (2.57 x 10(9) M-1), an increase that was not observed in treated animals either at day 30 or 70. These results suggest a sensitive period of imprinting during the first 7 days postnatally, a period when thyroxine can exert a permanent effect on later growth and later hepatic EGF receptor number.

Animals↗

Nerve growth factor levels in mouse serum: variations due to stress.

The presence of nerve growth factor (NGF) in the serum of adult male mice was assayed using the chick embryo dorsal root ganglion (DRG) bioassay technique in a serum free N1 supplemented medium. Wide variations in the serum-induced nerve fiber outgrowth response were observed when serum was obtained from animals maintained four per cage. Of 64 mice tested, sera of 7 animals induced a profound nerve fiber outgrowth response while the sera of 57 mice failed to show a similar response. In animals kept in isolation for 7 days prior to the start of the experiment, aggression provoked a marked increase in serum NGF levels. In contrast to the sera of aggression-unprovoked mice, the sera of all aggression-provoked mice stimulated a dense nerve fiber outgrowth. The sera of both groups of mice stimulated an intense proliferation and migration of nonneuronal cells. The neurite outgrowth responses elicited by sera from aggression-provoked and unprovoked mice were completely inhibited by the rabbit anti-NGF antiserum. In conclusion, both crowded housing and aggression in mice may provoke an elevation in the serum NGF levels that can be confirmed by the ganglion bioassay technique.

Aggression↗

Mouse saliva prevents the beta-nerve growth factor-dependent neurite formation in PC-12 cells.

A highly sensitive and specific competitive beta-nerve growth factor radioimmunoassay (beta NGF-RIA) was utilized to determine the beta NGF levels in epinephrine-provoked saliva of adult male and female Swiss-Webster mice. Saliva beta NGF levels in males were higher than in females. In order to assess the immunoreactive material measured in the RIA as biologically active beta NGF, saliva of male and female mice was examined for the neurite outgrowth responsiveness both in the rat pheochromocytoma tumor cell line (PC-12) and 8-day-old chick embryo dorsal root sensory ganglion (DRG) bioassay systems. At concentrations (based on the RIA values) sufficient to saturate both high and low affinity beta NGF-receptors (100 ng and above), saliva of both male and female mice did not elicit neurite outgrowth in the PC-12 bioassay system. In contrast, similar concentrations of saliva stimulated extensive neurites in the DRG bioassay system. When serum of aggression-provoked male mice (which also contained high serum beta NGF levels as indicated by the RIA) was tested, both the PC-12 and DRG bioassay systems readily responded with neurite extension. In the PC-12 bioassay system, saliva of both sexes stimulated cell proliferation and cell aggregation, but not cell substratum-adhesion. Addition of saliva also prevented the cell substratum adhesion and the formation of neurites induced by purified submandibular gland (SMG)-beta NGF. Epidermal growth factor (EGF), a potent mitogen present in mouse saliva, did not prevent the neurite outgrowth induced by the purified SMG-beta NGF. In summary, the results suggest that saliva of adult male and female mice may contain biologically interfering substances for beta NGF-dependent neurite formation in the PC-12 bioassay system.

Animals↗

Epidermal growth factor in synaptosomal fractions of mouse cerebral cortex.

Using a specific and sensitive epidermal growth factor radioimmunoassay (EGF-RIA) we measured EGF concentrations in whole brain, cerebral cortex, and cerebral cortical synaptosomal (pinched-off presynaptic nerve terminals) fractions of 26-day-old mouse brain. The relative EGF concentration in synaptosomal fractions was significantly greater than the growth factor concentrations in whole brain or cerebral cortex. Intracerebral injection, in an amount of EGF, several-fold greater than whole brain EGF content, did not appreciably increase synaptosomal EGF concentration, suggesting that no artifact was involved. The high synaptosomal EGF content suggests a neurotransmitter or a neuromodulator role for EGF in the CNS.

Animals↗

Beta-nerve growth factor measurements in mouse serum.

Mouse serum beta-nerve growth factor (NGF) levels were measured using a newly developed competitive beta-NGF radioimmunoassay. The basal serum beta-NGF levels in male and female mice were consistently less than 2 ng/ml when these animals were maintained in individual cages for at least 7 days before they were killed. However, in male mice, serum beta-NGF levels were significantly elevated when they were housed 5 per cage. The rise in serum beta-NGF levels, presumably mediated by intermale aggression, was confirmed by grouping previously isolated mice together in one cage for 20 min before they were killed. In all aggressive male mice, serum beta-NGF levels were elevated by two orders of magnitude. The beta-NGF radioimmunoassay values were also validated by a neurite outgrowth bioassay system using the serum of aggressive male mice. In summary, both measurement techniques confirm that mouse serum beta-NGF levels undergo marked changes depending on animal handling conditions.

Aggression↗

Aggressive behavior in adult male mice elevates serum nerve growth factor levels.

By use of a specific and sensitive beta-nerve growth factor radioimmunoassay (beta NGF-RIA), serum beta NGF concentrations were measured in adult male Swiss-Webster mice under various physiological conditions. Animals killed on the day of arrival from the animal supplier showed wide variations (3-15 ng beta NGF/ml) in serum beta NGF levels. These levels significantly decreased if the animals were maintained under individually housed conditions for at least 6 days prior to death. Aggression caused by social contact between previously individually housed animals raised serum beta NGF levels by two orders of magnitude relative to serum beta NGF concentrations in nonaggressive mice. Testosterone propionate treatment (10 mg/animal) 5 days prior to death did not elevate serum beta NGF levels in individually maintained animals. However, the hormone pretreatment markedly augmented serum beta NGF levels in aggressive mice compared with the levels in hormone-treated nonaggressive animals. Removal of the submandibular-sublingual salivary glands 10 days prior to death completely abolished the increase in serum beta NGF due to aggression. The high serum beta NGF levels, as measured by competitive RIA in aggressive mice, were confirmed by a neurite outgrowth PC-12 bioassay system. In conclusion, serum beta NGF in adult male mice is subject to alteration by environmental stress.

Aggression↗

Involvement of developing sympathetic nervous system in thyroxine-mediated submandibular gland nerve growth factor and epidermal growth factor responses.

Thyroxine (T4) administration in mice during the 2nd wk of postnatal life elicits a precocious increase in submandibular gland-nerve growth factor (SMG-NGF) and epidermal growth factor (SMG-EGF) levels, but the mechanism(s) of T4 action has not been studied. The present report examines the role of the developing sympathetic nervous system (SNS) in the SMG-NGF and EGF responses to T4. For this purpose newborn mice were injected with T4 and/or 6-hydroxydopamine, a toxic congener of norephinephrine which causes selective destruction of sympathetic nerve terminals. The effectiveness of chemical sympathectomy was assessed by SMG-norepinephrine measurements using a sensitive radioenzymatic assay. The glandular norepinephrine contents were greatly reduced indicating that the dose and duration of 6-OHDA treatment were sufficient to cause a total sympathectomy in SMG tissue. In addition, the 6-OHDA treatment greatly reduced the wet weight and total protein content of the sympathetic superior cervical ganglia which innervate SMG tissue. SMG-NGF and EGF concentrations were measured by specific radioimmunoassays. 6-OHDA treatment alone did not affect the basal SMG-NGF and EGF concentrations. However, the maximal responses of SMG-NGF and EGF to T4 administration were greatly reduced by concurrent treatment with 6-OHDA. In summary, the data demonstrate a critical role for developing sympathetic nervous system in the T4-stimulated increase in SMG-NGF and EGF concentrations.

Animals↗

Beta-nerve growth factor in developing mouse cerebral cortical synaptosomes: measurement by competitive radioimmunoassay and bioassay.

The existence of beta-nerve growth factor (beta NGF) in mouse cerebral cortical synaptosomal extracts was assessed using a newly developed radioimmunoassay and by bioassay. Displacement curves of labeled beta NGF in the radioimmunoassay by synaptosomal extracts were parallel to the beta NGF standard curves. In contrast, both mitochondrial and nonsynaptosomal extracts produced displacement curves in the beta NGF radioimmunoassay which were nonparallel to standard beta NGF. Intraventricular injections of purified beta NGF in amounts 5 and 100 ng/mouse (six to 120 times that of whole brain beta NGF concentrations) did not alter the endogenous synaptosomal beta NGF concentrations. Synaptosomal extracts contained beta NGF in relatively higher concentrations than the extracts of whole brain or cerebral cortex. Synaptosomal beta NGF levels undergo a developmental change. The beta NGF concentrations were highest in synaptosomal extracts of 12-day-old mouse cerebral cortex (the youngest age studied), and levels decreased with increasing age. Synaptosomal extracts of 12-day-old mouse cerebral cortex produced neurite outgrowth in the pheochromocytoma cell line 12 bioassay system and this response was completely inhibited by beta NGF antibodies. In the pheochromocytoma cell line 12 cell bioassay, synaptosomal extracts also caused cell-cell aggregation which was unaffected by beta NGF antibodies. These results provide evidence for the existence of beta NGF in relatively high concentration in nerve terminals of mouse cerebral cortex.

Animals↗